Back to Search
ADAM BENSON, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1548250426IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
11505(MT)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1998
Research & Publications (20)
Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers.
PMID 19638922·Ann Surg·2009
4-observational
Genomic instability in regions adjacent to a highly conserved pch prophage in Escherichia coli O157:H7 generates diversity in expression patterns of the LEE pathogenicity island.
PMID 19329643·J Bacteriol·2009
8-other
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.
PMID 19635226·J Natl Compr Canc Netw·2009
6-review
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one.
PMID 19631533·Bioorg Med Chem Lett·2009
7-preclinical
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
PMID 19581537·J Clin Oncol·2009
3-trial
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
PMID 19636013·J Clin Oncol·2009
8-other
Genomic regions conserved in lineage II Escherichia coli O157:H7 strains.
PMID 19329668·Appl Environ Microbiol·2009
7-preclinical
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system.
PMID 19539468·Bioorg Med Chem Lett·2009
7-preclinical
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
PMID 19496616·Biochemistry·2009
8-other
Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota.
PMID 19411417·Appl Environ Microbiol·2009
7-preclinical
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
PMID 19411100·Lancet·2009
3-trial
Understanding pharmacists' values: a qualitative study of ideals and dilemmas in UK pharmacy practice.
PMID 19410345·Soc Sci Med·2009
8-other
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
PMID 19406039·J Natl Compr Canc Netw·2009
6-review
Targeted single nucleotide polymorphism (SNP) discovery in a highly polyploid plant species using 454 sequencing.
PMID 19386042·Plant Biotechnol J·2009
8-other
NCCN task force: clinical utility of PET in a variety of tumor types.
PMID 19555588·J Natl Compr Canc Netw·2009
6-review
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.
PMID 19540112·Bioorg Med Chem Lett·2009
7-preclinical
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.
PMID 19663827·Br J Haematol·2009
6-review
'Mind and Body': a lifestyle programme for people on antipsychotic medication.
PMID 19335484·J Eval Clin Pract·2009
8-other
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
PMID 19267416·Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3205 S RUSSELL ST
MISSOULA, MT 59801 - Phone
- (406) 721-4906
Quick Facts
- NPI
- 1548250426
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile